REFERENCES
- Bonetti M., Gelber R. D. A graphical method to assess treatment-covariate interactions using the Cox model on subsets of the data. Stat. Med. 2000; 19: 2595–2609, [INFOTRIEVE], [CSA]
- Cox D. R. Regression models and lifetables (with discussion). J. Royal Stat Soc. B 1972; 34: 187–220, [CSA]
- Cox D. R. Partial likelihood. Biometrika 1975; 62: 269–276, [CROSSREF], [CSA]
- Fisher B., Jeong J. H., Bryant J., Anderson S., Dignam J., Fisher E. R., Wolmark N. Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomized clinical trials. Lancet 2004; 364: 858–868, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Cleveland W. S., Delven S. J. Locally weighted regression: an approach to regression analysis by local fitting. J. Am. Stat. Associ. 1988; 83: 596–610, [CSA]
- Fisher B., Costantino J., Redmond C., Poisson R., Bowman D., et al. A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. N. Engl. J. Med. 1989; 320: 479–484, [INFOTRIEVE], [CSA]
- Fisher B., Dignam J., Wolmark N., DeCillis A., Emir B., et al. Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer. J. Nat. Cancer Inst. 1997; 89: 1673–1682, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]